Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin.
JACC Basic Transl Sci
; 4(5): 575-591, 2019 Sep.
Article
em En
| MEDLINE
| ID: mdl-31768475
CM, cardiomyocyte; CMEC, cardiac microvascular endothelial cell; Ca, calcium; DM, diabetes mellitus; DPPH, 1,1-diphenyl-picrylhydrazyl; EC, endothelial cell; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; JNK, Jun N-terminal kinase; L-NAME, N(ω)-nitro-L-arginine methyl ester; LV, left ventricular; NK-κB, nuclear factor-κB; NO, nitric oxide; ROS, reactive oxygen species; SGLT2, sodium glucose transporter 2; contraction and relaxation; eNOS, endothelial nitric oxide synthase; empagliflozin; endothelial cellderived nitric oxide; heart failure; oxidative stress
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
Idioma:
En
Revista:
JACC Basic Transl Sci
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Holanda